Café

© 2026 Longbridge｜Terms of Service Privacy Policy

ZBIO

ZBIO

33.7706.70%( +2.120 )

LongbridgeAI

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD | ZBIO Stock News

StockTitan

May 27, 2026 at 10:05 PM

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD | ZBIO Stock News

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD | ZBIO Stock News

Login to unlock131characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Zenas Biopharma

ZBIO.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--